BioInvent
Ideon Science and Technology Park
Sölvegatan 41
Lund
S-223 70
Tel: 46-46-286-8550
Fax: 46-46-211-0806
Website: http://www.bioinvent.com/
Email: info@bioinvent.com
311 articles about BioInvent
-
BioInvent International AB Annual General Meeting
4/25/2013
-
BioInvent Interim Report 1 January – 31 March 2013
4/25/2013
-
BioInvent Annual General Meeting
4/25/2013
-
BioInvent Initiates Clinical Trial With BI-505 in Smoldering Myeloma
4/22/2013
-
BioInvent Release: Preclinical Data Published in Cancer Cell Highlight Novel Antibody BI-505 and Potent Anti-Myeloma Activity
4/16/2013
-
BioInvent Financial Statement
2/21/2013
-
BioInvent: Positive Results From the BI-505 Phase I Study in Multiple Myeloma
1/24/2013
-
BioInvent Recruits New CEO
1/9/2013
-
BioInvent Interim Report 1 January - 30 September 2012
10/18/2012
-
BioInvent Cuts More Jobs and Refocuses
10/2/2012
-
BioInvent Interim Report
7/19/2012
-
Blow for BioInvent as Vascular Treatment Fails
7/11/2012
-
BioInvent Cuts Jobs, Reorganizes
6/29/2012
-
BioInvent and Cancer Research Technology Enter Oncology Collaboration
6/12/2012
-
ThromboGenics NV and BioInvent to Regain Full Rights to TB-403
6/5/2012
-
BioInvent, ThromboGenics NV Plunges as Development of Anticoagulent is Dropped
6/5/2012
-
BioInvent Interim Report 1 January – 31 March 2012
5/2/2012
-
BioInvent Annual General Meeting
3/26/2012
-
BioInvent Release: Extraordinary General Meeting Approved Rights Issue
3/9/2012
-
BioInvent Release: Recruitment of Patients Completed in Phase II Study with BI-204
3/2/2012